Study phase

WikiDoc Resources for Study phase
Articles
Most recent articles on Study phase Most cited articles on Study phase Review articles on Study phase Articles on Study phase in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Study phase Images of Study phase Photos of Study phase Podcasts & MP3s on Study phase Videos on Study phase
Evidence Based Medicine
Cochrane Collaboration on Study phase Bandolier on Study phase TRIP on Study phase
Clinical Trials
Ongoing Trials on Study phase at Clinical Trials.gov Trial results on Study phase Clinical Trials on Study phase at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Study phase NICE Guidance on Study phase NHS PRODIGY Guidance FDA on Study phase CDC on Study phase
Books
Books on Study phase
News
Study phase in the news Be alerted to news on Study phase News trends on Study phase
Commentary
Blogs on Study phase
Definitions
Definitions of Study phase
Patient Resources / Community
Patient resources on Study phase Discussion groups on Study phase Patient Handouts on Study phase Directions to Hospitals Treating Study phase Risk calculators and risk factors for Study phase
Healthcare Provider Resources
Symptoms of Study phase Causes & Risk Factors for Study phase Diagnostic studies for Study phase Treatment of Study phase
Continuing Medical Education (CME)
CME Programs on Study phase
International
Study phase en Espanol Study phase en Francais
Business
Study phase in the Marketplace Patents on Study phase
Experimental / Informatics
List of terms related to Study phase

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Phase I Trials

These are initial studies to determine the metabolism and pharmacologic actions of drugs in humans (what are called PK/PD studies or pharmacokinetic / pharmacodynamic studies), the side effects associated with increasing doses (a dose response curve or dose response relationship), and to gain early evidence of effectiveness; may include healthy participants and/or patients. These are sometimes called a first in man study.

Phase II Trials

Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. Sometimes multiple doses will be studied in these trials to select the appropriate dose for further testing in phase III. These are sometimes called a dose finding study.

Phase III Trials

Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. These are also called pivotal trials.

Phase IV Trials

After the drug has been approved by a regulatory agency, these are post-marketing studies to delineate additional information including the drug's risks,benefits, and optimal use in a broader group of real world patients.